Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
78% of People Surveyed Want More Holistic Health Support This Season Manitoba Harvest. Manitoba Harvest. MINNEAPOLIS and WINNIPEG, Manitoba, Dec....
News
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline readout of clinical trial results anticipated in first...
Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine
Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against multiple SARS-CoV-2 variantsCAMBRIDGE, Mass., Dec....
Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy
- DYNE-251, Dyne’s First DMD Program, is Being Developed for Patients with Mutations Amenable to Skipping Exon 51 - -...
Streamline Health® To Report Third Quarter 2021 Financial Performance and Provide Corporate Update
ATLANTA, GA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity...
Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan
NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2 to 6 months after NDA resubmissionNo additional...
SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
PPF Group provides funding to advance SOTIO through key clinical milestonesProceeds shall be used to conduct two phase 2 studies...
Premier Health Announces the Appointment of Eric Dupont as Its New CTO
MONTRÉAL, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a...
Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003
SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow
BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that President...
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
Simcyp Simulator has been used to inform more than 250 label claims for 85+ novel drugsPRINCETON, N.J., Dec. 02, 2021...
Replimune Appoints Christy Oliger to its Board of Directors
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing a range of...
Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies
Visionary technology investor Samuel Chen to join Board of DirectorsALAMEDA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Acepodia, a clinical-stage...
Brooklyn ImmunoTherapeutics to Present at Two Upcoming December Conferences
NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring...
GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program
Grant of $400,000 to help expand sickle cell disease real-world data gathering in the U.S.WASHINGTON and SOUTH SAN FRANCISCO, Calif.,...
Merus Announces Poster Presentation on Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”,...
Onconova Therapeutics Announces the Presentation of Preliminary Clinical Data Providing Evidence of Rigosertib’s Activity in RDEB-associated Squamous Cell Carcinoma
Initial single patient data in this ultra-rare indication show that rigosertib monotherapy led to sustained complete response of all target...
Delcath Systems, Inc. Announces Positive Phase 3 FOCUS Trial Results for Hepzato™ in Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis
On final analysis of the primary overall response (ORR) endpoint, HEPZATO further exceeded the predefined threshold for success with a...
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting
SEATTLE, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
